Penelope Kokkinides has an interesting history with InnovaCare. She’s one of the few members of the company’s leadership to have worked with the company twice. The first time she worked with InnovaCare, she served as COO. She left to take higher-ranking positions at other companies.In 2015, she rejoined the company but didn’t get her old job back; that position was filled already. She rejoined the company as its new Chief Administrative Officer. While working for InnovaCare, she also worked for Aveta Inc. There, she served as VP of Clinical Operations; giving her a taste of higher corporate positions.Kokkinides is one of the most educated members of the InnovaCare family. She holds as biological sciences Bachelor’s degree from Binghamton University. She also holds two Master’s degrees, one a post-master’s advanced degree, from Columbia University School of Public Health. She also holds another Master’s degree from New York University.
While working at other companies, Kokkinides took on more responsibilities. As Executive VP of Centerlight HealthCare, she was responsible the managed care division’s strategic development. She also played a huge role in developing and implementing AmeriChoice’s new health model.InnovaCare Health is a leading company in the managed care industry. It’s an industry many people know nothing about. Part of the reason for that is due to all the complexities of today’s healthcare environment. InnovaCare Health’s mission is to reduce the number of challenges people face when trying to get much-needed medical care.
InnovaCare’s main focus is its patients. Everything InnovaCare does is for the benefit of patient health. That’s why patient-provider relationships are the company’s lifeline to building successful models of managed care. The stronger the relationship; the easier it is to provide each patient with quality medical care.One of the brighter stars at the company is Dr. Richard Shinto. Dr. Shinto serves as President and CEO of InnovaCare, Inc. He has over 20 years of experience in clinical and operational healthcare. His contributions to the company are well-documented in Penelope Kokkinides’s success. He’s even the CEO of one of the company’s subsidiaries.When he first joined InnovaCare, he was still working with Aveta Inc. After its sale in 2012, he dedicated himself entirely to InnovaCare. Dr. Shinto is still a practicing physician, specializing as an internist and pulmonologist.
The expenses incurred when receiving health care can eat up a whole monthly paycheck from a single family. Receiving health care in the United States of America is absurdly expensive compared to other states. According to reports from the medical department, health insurance is expensive. It has taken the partnership of various health care organizations to arrive at a workable solution that will make health care systems provide not only affordable insurance but also high-quality health care services. One organization that works towards converging resources to develop high-quality health care systems is Foresite Capital owned by Jim Tananbaum. In his words, medical innovation is mind boggling as it consumes a lot of capital and resources.
Jim is the chief executive officer of Foresite Capital. He is also the brain behind the establishment of the company. He established the company in 2011. This company is entirely dedicated to identifying emerging leaders in the health care sector and using these leaders to better the health care system by providing useful resources. Some of these resources include capital, health care related networks and valuable data. Asked where the idea to establish Foresite Capital rooted from, Jim explained that he has twenty-five years’ experience in entrepreneurship. He has worked in healthcare sectors for a long time. Throughout his business career, he discovered that health care systems need empowerment. He identified primary success factors that would help not only entrepreneurs but also companies and patients.
Before he established Foresite Capital, Jim worked in various organizations where he amassed extensive experience. He was the co- founder of a pharmaceutical company called GelTex Pharmaceuticals. This company was a success story for Jim. It produced a powerful drug called Renagel which was sold at $80 million. GelTex was sold in 1998 when its leading product Renzela made profit revenues of approximately $ 200 million. It is projected that the drug’s current worth is $ 1 billion. Another pharmaceutical company Jim co-founded is Theravance. He was the president of the firm. Under his leadership, he saw the company partnering with GSK to produce a respiratory franchise. Through Foresite Capital his current success story, Jim maintains a high profile of partnerships to better the health care system. You can visit Crunchbase to know more.
See more: https://www.linkedin.com/in/jim-tananbaum-a7562a7/